Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 298M | 256M | 486M | 366M |
| Cost of revenue | 122M | 123M | 135M | 117M |
| Gross profit | 176M | 133M | 351M | 249M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 10M | 10M | 9M | 9M |
| Other operating expenses | — | — | — | — |
| Operating income | 3M | -33M | 178M | 87M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 116M | 23M | 139M | 88M |
| Other income expense | 9M | 8M | 21M | 15M |
| Pretax income | -104M | -48M | 60M | 14M |
| Tax provision | 0 | 0 | 33M | 10M |
| Net income | -104M | -48M | 27M | 4M |
| Basic EPS | 0.0 | — | 0.3 | 0.4 |
| Diluted EPS | 0.0 | — | 0.3 | 0.4 |
| Basic average shares | 118M | — | 118M | 117M |
| Diluted average shares | 118M | — | 118M | 117M |
| EBITDA | 221M | 182M | 409M | 305M |
| Net income from continuing op. | -104M | -48M | 27M | 4M |
| Minority interests | 108M | 51M | 9M | 47M |
| Preferred stock dividends | — | — | — | — |